National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

canertinib dihydrochloride (can-ER-tih-nib dy-HY-droh-KLOR-ide)

 A substance being studied in the treatment of some types of cancer. Canertinib dihydrochloride blocks the action of proteins called epidermal growth factor receptors, and may cause cancer cells to die. It is a type of tyrosine kinase inhibitor. Also called canertinib and CI-1033.



Previous Definitions:cancer of unknown primary origin, cancer vaccine, candidiasis, candidosis, canertinib
Next Definitions:Cantron, CAP-1, capecitabine, capillary, capillary leak syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov